Hu-CD8/CD38/CD3/HLA-DR 4 Color FCM Reagent: sc-2910
Santa Cruz
Abstract
Santa Cruz
Abstract
BACKGROUND Human CD8/CD38/CD3/HLA-DR: sc-2910 is a direct immunofluorescence reagent formatted to identify the percentage of activated T-suppressor/cytotoxic lymphocytes (1) in erythrocytelysed whole blood, based on cell-surface antigen expression. CD8 identifies suppressor/cytotoxic T lymphocytes and binds class I MHC molecules, which enhances the activation of resting T lymphocytes (2). CD38 is expressed during the early and final stages of T and B cell differentiation, but not during the intermediate stage (3). CD3 identifies T lymphocytes and noncovalently associates with either α/β or γ/δ TCR (4). HLA-DR is expressed on B lymphocytes, monocytes, macrophages, activated T lymphocytes and human progenitor cells (5). Reductions in the percentage and absolute number of CD4+ cells, as well as abnormally high levels of activated peripheral T cells and an increased proportion of CD8+ cells coexpressing CD57 (involved in NK activity) have been reported in HIV infection and associated with disease progression (1).
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
BACKGROUND Human CD8/CD38/CD3/HLA-DR: sc-2910 is a direct immunofluorescence reagent formatted to identify the percentage of activated T-suppressor/cytotoxic lymphocytes (1) in erythrocytelysed whole blood, based on cell-surface antigen expression. CD8 identifies suppressor/cytotoxic T lymphocytes and binds class I MHC molecules, which enhances the activation of resting T lymphocytes (2). CD38 is expressed during the early and final stages of T and B cell differentiation, but not during the intermediate stage (3). CD3 identifies T lymphocytes and noncovalently associates with either α/β or γ/δ TCR (4). HLA-DR is expressed on B lymphocytes, monocytes, macrophages, activated T lymphocytes and human progenitor cells (5). Reductions in the percentage and absolute number of CD4+ cells, as well as abnormally high levels of activated peripheral T cells and an increased proportion of CD8+ cells coexpressing CD57 (involved in NK activity) have been reported in HIV infection and associated with disease progression (1).
Key concepts: Cytotoxic T cell, CD8, CD38, CD3, Molecular biology, Biology, Human leukocyte antigen, T lymphocyte